Learning curves of theta/beta neurofeedback in children with ADHD

Tieme W P Janssen, Marleen Bink, Wouter D Weeda, Katleen Geladé, Rosa van Mourik, Athanasios Maras, Jaap Oosterlaan, Tieme W P Janssen, Marleen Bink, Wouter D Weeda, Katleen Geladé, Rosa van Mourik, Athanasios Maras, Jaap Oosterlaan

Abstract

Neurofeedback is widely applied as non-pharmacological intervention aimed at reducing symptoms of ADHD, even though efficacy has not been unequivocally established. Neuronal changes during the neurofeedback intervention that resemble learning can provide crucial evidence for the feasibility and specificity of this intervention. A total of 38 children (aged between 7 and 13 years) with a DSM-IV-TR diagnosis of ADHD, completed on average 29 sessions of theta (4-8 Hz)/beta (13-20 Hz) neurofeedback training. Dependent variables included training-related measures as well as theta and beta power during baseline and training runs for each session. Learning effects were analyzed both within and between sessions. To further specify findings, individual learning curves were explored and correlated with behavioral changes in ADHD symptoms. Over the course of the training, there was a linear increase in participants' mean training level, highest obtained training level and the number of earned credits (range b = 0.059, -0.750, p < 0.001). Theta remained unchanged over the course of the training, while beta activity increased linearly within training sessions (b = 0.004, 95% CI = [0.0013-0.0067], p = 0.005) and over the course of the intervention (b = 0.0052, 95% CI = [0.0039-0.0065], p < 0.001). In contrast to the group analyses, significant individual learning curves were found for both theta and beta over the course of the intervention in 39 and 53%, respectively. Individual learning curves were not significantly correlated with behavioral changes. This study shows that children with ADHD can gain control over EEG states during neurofeedback, although a lack of behavioral correlates may indicate insufficient transfer to daily functioning, or to confounding reinforcement of electromyographic activity.

Clinical trials registration: This trial is registered at the US National Institutes of Health (ClinicalTrials.gov, ref. no: NCT01363544); https://ichgcp.net/clinical-trials-registry/NCT01363544 .

Keywords: ADHD; EEG; Learning curves; Neurofeedback; Paediatric; Theta/beta-training.

Conflict of interest statement

None of the authors has a conflict of interest in the conduct and reporting of this study.

Figures

Fig. 1
Fig. 1
Schematic representation of the neurofeedback intervention. Approximately 3 sessions of neurofeedback were provided in a week, with 30 sessions taking 10 weeks. Each neurofeedback session started with a 1-min theta/beta baseline recording, which was used for the remaining of the session. A session consisted of 10 runs of 2 min each (20 min effective training). Each run comprised 4 trials of 30 s. Children were instructed to decrease theta/beta compared to the baseline recording during each trial. Children were rewarded with credits related to the size of the improvements compared to baseline. The training level increased or decreased based on performance of former runs and ranged between 3 and 52%. Training level increased after two successive runs with three successful trials each or after one run with four successful trials. Training level decreased after two successive runs with only one successful trial or after one run with no successful trials
Fig. 2
Fig. 2
EEG learning effects during neurofeedback. These graphs show changes in theta and beta power (μV2) during 1-min baseline EEG recordings preceding each neurofeedback session, across sessions (1–30) and within sessions (runs 1–10). The bold lines are means, and the upper and lower lines are 95% confidence intervals. **p < 0.01, ***p < 0.001

References

    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Publishing Inc; 2000.
    1. American Psychiatric Association (2013) Diagnostic and statitical manual of mental disorders, 5th ed. Washington, DC
    1. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19:353–364. doi: 10.1007/s00787-009-0054-3.
    1. Greenhill LL, Gwanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40:180–187. doi: 10.1097/00004583-200102000-00012.
    1. van de Loo-Neus GHH, Rommelse N, Buitelaar JK. To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol. 2011;21:584–599. doi: 10.1016/j.euroneuro.2011.03.008.
    1. Ahmed R, McCaffery KJ, Aslani P. Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2013;23:163–178. doi: 10.1089/cap.2012.0087.
    1. Sonuga-Barke EJS, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170:275–289. doi: 10.1176/appi.ajp.2012.12070991.
    1. Cortese S. The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol. 2012;16:422–433. doi: 10.1016/j.ejpn.2012.01.009.
    1. Snyder SM, Hall JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol. 2006;23:440–455. doi: 10.1097/01.wnp.0000221363.12503.78.
    1. Banaschewski T, Brandeis D. Annotation: what electrical brain activity tells us about brain function that other techniques cannot tell us—a child psychiatric perspective. J Child Psychol Psychiatry. 2007;48:415–435. doi: 10.1111/j.1469-7610.2006.01681.x.
    1. Loo SK, Barkley RA. Clinical utility of EEG in attention deficit hyperactivity disorder. Appl Neuropsychol. 2005;12:64–76. doi: 10.1207/s15324826an1202_2.
    1. Loo SK, Makeig S. Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update. Neurotherapeutics. 2012;9:569–587. doi: 10.1007/s13311-012-0131-z.
    1. Gevensleben H, Rothenberger A, Moll GH, Heinrich H. Neurofeedback in children with ADHD: validation and challenges. Expert Rev Neurother. 2012;12:447–460. doi: 10.1586/ern.12.22.
    1. Lofthouse N, Arnold LE, Hersch S, et al. A review of neurofeedback treatment for pediatric ADHD. J Atten Disord. 2012;16:351–372. doi: 10.1177/1087054711427530.
    1. Moriyama TS, Polanczyk G, Caye A, et al. Evidence-based information on the clinical use of neurofeedback for ADHD. Neurotherapeutics. 2012;9:588–598. doi: 10.1007/s13311-012-0136-7.
    1. Gevensleben H, Holl B, Albrecht B, et al. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry. 2009;50:780–789. doi: 10.1111/j.1469-7610.2008.02033.x.
    1. Steiner NJ, Frenette EC, Rene KM, et al. In-school neurofeedback training for ADHD: sustained improvements from a randomized control trial. Pediatrics. 2014;133:483–492. doi: 10.1542/peds.2013-2059.
    1. Arnold LE, Lofthouse N, Hersch S, et al. EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord. 2013;17:410–419. doi: 10.1177/1087054712446173.
    1. Perreau-Linck E, Lessard N, Lévesque J, Beauregard M. Effects of neurofeedback training on inhibitory capacities in ADHD children: a single-blind, randomized, placebo-controlled study. J Neurother. 2010;14:229–242. doi: 10.1080/10874208.2010.501514.
    1. van Dongen-Boomsma M, Vollebregt MA, Slaats-Willemse D, Buitelaar JK. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2013;74:821–827. doi: 10.4088/JCP.12m08321.
    1. Zuberer A, Brandeis D, Drechsler R. Are treatment effects of neurofeedback training in children with ADHD related to the successful regulation of brain activity? A review on the learning of regulation of brain activity and a contribution to the discussion on specificity. Front Hum Neurosci. 2015;9:135. doi: 10.3389/fnhum.2015.00135.
    1. Lubar JF, Swartwood MO, Swartwood JN, O’Donnell PH. Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance. Biofeedback Self Regul. 1995;20:83–99. doi: 10.1007/BF01712768.
    1. Monastra VJ, Monastra DM, George S. The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Appl Psychophysiol Biofeedback. 2002;27:231–249. doi: 10.1023/A:1021018700609.
    1. Leins U, Goth G, Hinterberger T, et al. Neurofeedback for children with ADHD: a comparison of SCP and theta/beta protocols. Appl Psychophysiol Biofeedback. 2007;32:73–88. doi: 10.1007/s10484-007-9031-0.
    1. Bink M, van Nieuwenhuizen C, Popma A, et al. Behavioral effects of neurofeedback in adolescents with ADHD: a randomized controlled trial. Eur Child Adolesc Psychiatry. 2014
    1. Gevensleben H, Holl B, Albrecht B, et al. Distinct EEG effects related to neurofeedback training in children with ADHD: a randomized controlled trial. Int J Psychophysiol. 2009;74:149–157. doi: 10.1016/j.ijpsycho.2009.08.005.
    1. Janssen TWP, Bink M, Geladé K, et al. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD. J Child Psychol Psychiatry. 2016;57:633–644. doi: 10.1111/jcpp.12517.
    1. Ogrim G, Hestad KA. Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: a randomized pilot study. J Child Adolesc Psychopharmacol. 2013;23:448–457. doi: 10.1089/cap.2012.0090.
    1. Schlegelmilch F, Markert S, Berkes S, Schellhorn K. Online ocular artifact removal for dc-EEG-signals: estimation of dc-level. Biomed Tech. 2004;2:340–341.
    1. Gratton G, Coles M, Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol. 1983;55:468–484. doi: 10.1016/0013-4694(83)90135-9.
    1. Swanson JM, Schuck S, Mann M et al (2001) Categorical and dimensional definitions and evaluations of symptoms of ADHD: The SNAP and the SWAN rating scales
    1. Loo SK, Cho A, Hale TS, et al. Characterization of the theta to beta ratio in ADHD: identifying potential sources of heterogeneity. J Atten Disord. 2013;17:384–392. doi: 10.1177/1087054712468050.
    1. Snyder SM, Rugino T a., Hornig M, Stein MA (2015) Integration of an EEG biomarker with a clinician’s ADHD evaluation. Brain Behav 5:n/a-n/a. doi: 10.1002/brb3.330
    1. Sherlin LH, Arns M, Lubar J, et al. Neurofeedback and basic learning theory: implications for research and practice. J Neurother. 2011;15:292–304. doi: 10.1080/10874208.2011.623089.
    1. Goncharova I, McFarland D, Vaughan T, Wolpaw J. EMG contamination of EEG: spectral and topographical characteristics. Clin Neurophysiol. 2003;114:1580–1593. doi: 10.1016/S1388-2457(03)00093-2.
    1. McMenamin BW, Shackman AJ, Greischar LL, Davidson RJ. Electromyogenic artifacts and electroencephalographic inferences revisited. Neuroimage. 2011;54:4–9. doi: 10.1016/j.neuroimage.2010.07.057.
    1. Gasser T, Verleger R, Bächer P, Sroka L. Development of the EEG of school-age children and adolescents. I. Analysis of band power. Electroencephalogr Clin Neurophysiol. 1988;69:91–99. doi: 10.1016/0013-4694(88)90204-0.
    1. Somsen RJM, van’t Klooster BJ, van der Molen MW et al (1997) Growth spurts in brain maturation during middle childhood as indexed by EEG power spectra. Biol Psychol 44:187–209. doi: 10.1016/S0301-0511(96)05218-0
    1. Janssen TWP, Bink M, Gelad K, et al. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD. J Child Psychol Psychiatry Allied Discip. 2016;57:633–644. doi: 10.1111/jcpp.12517.
    1. Lubar JO, Lubar JF. Electroencephalographic biofeedback of SMR and beta for treatment of attention deficit disorders in a clinical setting. Biofeedback Self Regul. 1984;9:1–23. doi: 10.1007/BF00998842.
    1. Geladé K, Janssen TWP, Bink M, et al (2016) Behavioral effects of neurofeedback compared to stimulants and physical activity in attention-deficit/hyperactivity disorder: a randomized controlled trial. J Clin Psychiatry
    1. Janssen TWP, Bink M, Geladé K, et al (2016) A randomized controlled trial investigating the effects of neurofeedback, methylphenidate, and physical activity on event-related potentials in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 26:cap.2015.0144. doi: 10.1089/cap.2015.0144

Source: PubMed

3
구독하다